Is ulcerative colon cancer contagious?

The treatment of colorectal cancer is surgical resection of the tumor as the first choice, supplemented by radiotherapy, chemotherapy drugs and conservative treatment of traditional Chinese medicine. Surgery is only palliative resection or symptomatic treatment.

After surgery, the body's vitality is damaged, and ginsenoside RH2 is generally used to improve the success rate of surgery and reduce the recurrence and metastasis of tumors. Chinese and Western medicine have their own strengths in treating tumors, so the treatment of colorectal cancer must give full play to the respective advantages of Chinese medicine, insist on long-term treatment, relax the patient's psychological state, do a good job of psychological treatment, increase dietary nutrition, and improve the body's immune function. In this way, better results can be achieved.

About 1/3 to 1/4 of colorectal cancer cases are in the late stage, and about 50% of them will have recurrence and metastasis within 5 years after diagnosis. The current radiotherapy and chemotherapy regimens are relatively mature and most of them are effective. Studies have shown that combining ginsenoside RH2 before, during and after radiotherapy and chemotherapy can effectively enhance efficacy and reduce toxicity, shorten the recovery period and prevent recurrence and metastasis.

The existing literature supports the inhibitory effect of ginsenoside Rh2 on the growth of human colon cancer cell lines SW620 and LOVO. The current survival period of colorectal cancer is still relatively good. The prognosis should be reviewed more often, and attention should be paid to daily life patterns, especially dietary patterns.